JPWO2021235508A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021235508A5
JPWO2021235508A5 JP2022524526A JP2022524526A JPWO2021235508A5 JP WO2021235508 A5 JPWO2021235508 A5 JP WO2021235508A5 JP 2022524526 A JP2022524526 A JP 2022524526A JP 2022524526 A JP2022524526 A JP 2022524526A JP WO2021235508 A5 JPWO2021235508 A5 JP WO2021235508A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
formula
fatty liver
liver disease
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022524526A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021235508A1 (https=
JP7820294B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/019088 external-priority patent/WO2021235508A1/ja
Publication of JPWO2021235508A1 publication Critical patent/JPWO2021235508A1/ja
Publication of JPWO2021235508A5 publication Critical patent/JPWO2021235508A5/ja
Application granted granted Critical
Publication of JP7820294B2 publication Critical patent/JP7820294B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022524526A 2020-05-21 2021-05-20 脂肪性肝疾患の治療用医薬 Active JP7820294B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2020089196 2020-05-21
JP2020089196 2020-05-21
JP2020134338 2020-08-07
JP2020134338 2020-08-07
PCT/JP2021/019088 WO2021235508A1 (ja) 2020-05-21 2021-05-20 脂肪性肝疾患の治療用医薬

Publications (3)

Publication Number Publication Date
JPWO2021235508A1 JPWO2021235508A1 (https=) 2021-11-25
JPWO2021235508A5 true JPWO2021235508A5 (https=) 2024-05-27
JP7820294B2 JP7820294B2 (ja) 2026-02-25

Family

ID=78707930

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022524526A Active JP7820294B2 (ja) 2020-05-21 2021-05-20 脂肪性肝疾患の治療用医薬

Country Status (10)

Country Link
US (2) US12521375B2 (https=)
EP (1) EP4154880A4 (https=)
JP (1) JP7820294B2 (https=)
KR (1) KR20230013126A (https=)
CN (1) CN115666558A (https=)
AU (1) AU2021275292A1 (https=)
CA (1) CA3182134A1 (https=)
MX (1) MX2022014553A (https=)
TW (1) TW202207919A (https=)
WO (1) WO2021235508A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4434520A4 (en) 2021-11-19 2025-10-29 Shionogi & Co PHARMACEUTICAL PRODUCT FOR THE TREATMENT OF HEART DISEASE OR SKELETAL MUSCLE DISEASE

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004523225A (ja) 2000-12-26 2004-08-05 リサーチ ディベロップメント ファンデーション 脂肪燃焼、脂肪蓄積、エネルギーホメオスタシス及びインシュリン作用の調節を標的とするアセチルコエンザイムaカルボキシラーゼ2
US6548738B2 (en) 2000-12-26 2003-04-15 Research Development Foundation ACC2-knockout mice and uses thereof
US20110009443A1 (en) * 2008-05-28 2011-01-13 Kevin Daniel Freeman-Cook Pyrazolospiroketone Acetyl-Coa Carboxylase Inhibitors
WO2011058474A1 (en) 2009-11-10 2011-05-19 Pfizer Inc. N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
BR112013010310A2 (pt) 2010-10-29 2016-11-29 Pfizer inibidores de acetil-coa carboxilase de lactama n1/n2
LT2776038T (lt) 2011-11-11 2018-04-25 Gilead Apollo, Llc Acc inhibitoriai ir jų panaudojimas
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
JP6205152B2 (ja) 2013-03-25 2017-09-27 サイプレス セミコンダクター コーポレーション シリアル通信システム、受信装置およびシリアル通信方法
EP3670496A3 (en) 2013-10-17 2020-09-30 Shionogi&Co., Ltd. Acc2 inhibitors
JP2016079168A (ja) 2014-10-17 2016-05-16 塩野義製薬株式会社 9員縮合環誘導体
JP2018501276A (ja) 2015-01-09 2018-01-18 ギリアド アポロ, エルエルシー 非アルコール性脂肪肝疾患の処置のためのacc阻害剤併用療法
EA201892201A1 (ru) * 2016-03-30 2019-03-29 Женфит Неинвазивная диагностика неалкогольного стеатогепатита
US11541046B2 (en) 2017-06-30 2023-01-03 Quixgen, Inc. Spirolactone compounds

Similar Documents

Publication Publication Date Title
JP2019034943A5 (https=)
JP2017529389A5 (https=)
JP2024050527A5 (https=)
JP2014015465A5 (https=)
JP2018510139A5 (https=)
JP2020528889A5 (https=)
JP2013510885A5 (https=)
JP2010532768A5 (https=)
JP2018514568A5 (https=)
JP2019519598A5 (https=)
JP2018518537A5 (https=)
JP2020507589A5 (https=)
JP2015505296A5 (https=)
JP2017515854A5 (https=)
JP2017531013A5 (https=)
JP2017505293A5 (https=)
JP2015051983A5 (https=)
JP2008500999A5 (https=)
JP2012532883A5 (https=)
JP2016510326A5 (https=)
JP2016501838A5 (https=)
JPWO2023106310A5 (https=)
JP2005539026A5 (https=)
JP2020505354A5 (https=)
JP2017505785A5 (https=)